US2957906A
(en)
*
|
1955-10-25 |
1960-10-25 |
Monsanto Chemicals |
Ketones
|
US3022268A
(en)
|
1958-07-17 |
1962-02-20 |
Du Pont |
Polyethylene composition
|
JPS5752354B2
(zh)
*
|
1973-10-22 |
1982-11-06 |
|
|
US3980674A
(en)
*
|
1974-01-28 |
1976-09-14 |
Delmar Chemicals Limited |
2,3-Disubstituted 7-oxabicyclo-[2.2.1]-5-heptene
|
US3954913A
(en)
*
|
1975-01-06 |
1976-05-04 |
The Standard Oil Company |
Stabilized nitrile polymers
|
JPS5188631A
(en)
|
1975-01-31 |
1976-08-03 |
|
Hiiryoyosatsukinzai oyobi sonoseizoho
|
US4143054A
(en)
*
|
1977-11-04 |
1979-03-06 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane- and 7-oxabicycloheptene compounds
|
US4218478A
(en)
*
|
1979-01-05 |
1980-08-19 |
Ruiko Oiwa |
Trichostatin as an antiprotozoal agent
|
US4298752A
(en)
*
|
1980-09-19 |
1981-11-03 |
Regents Of The University Of California |
Cycloadduct precursors of cantharidin and method
|
US4410681A
(en)
|
1982-03-22 |
1983-10-18 |
The Dow Chemical Company |
Epoxy resins cured with salicyloyl hydrocarbylamines
|
US4614825A
(en)
*
|
1982-05-17 |
1986-09-30 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane and 7-oxabicycloheptene compounds
|
US4463015A
(en)
*
|
1982-08-18 |
1984-07-31 |
E. R. Squibb & Sons, Inc. |
Aryl substituted 7-oxabicycloheptane compounds, useful in inhibiting platelet aggregation
|
US4524151A
(en)
|
1983-11-14 |
1985-06-18 |
E. R. Squibb & Sons, Inc. |
7-Oxabicycloheptane thio ethers useful as cardiovascular agents
|
JPS61176523A
(ja)
*
|
1985-01-30 |
1986-08-08 |
Teruhiko Beppu |
制癌剤
|
US4654355A
(en)
*
|
1985-08-01 |
1987-03-31 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane substituted amide-thioamide prostaglandin analogs
|
US4851553A
(en)
*
|
1986-06-04 |
1989-07-25 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane amido-carboxylic acids
|
US4816579A
(en)
*
|
1986-06-04 |
1989-03-28 |
E. R. Squibb & Sons, Inc. |
7-oxabicycloheptane amino-alcohol intermediates useful in making thromboxane A2 receptor antagonists
|
US4851423A
(en)
|
1986-12-10 |
1989-07-25 |
Schering Corporation |
Pharmaceutically active compounds
|
SU1553533A1
(ru)
|
1988-01-28 |
1990-03-30 |
Военная Краснознаменная академия химической защиты им.Маршала Советского Союза С.К.Тимошенко |
Способ получени 1,4-бисполифторалкил-7-оксбицикло [2.2.1]гептанов
|
US5047574A
(en)
*
|
1988-12-14 |
1991-09-10 |
Shionogi & Co., Ltd. |
Certain optically active mono esters of dicarboxylic acids
|
RU2015980C1
(ru)
*
|
1990-02-06 |
1994-07-15 |
Е.Р.Сквибб энд Санз, Инк. |
7-оксабициклогептилзамещенные гетероциклические амиды или их стереоизомеры в качестве антагонистов рецепторов тромбоксана
|
US5763647A
(en)
*
|
1990-03-30 |
1998-06-09 |
Shionogi & Co., Ltd. |
Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives
|
US5266710A
(en)
*
|
1990-12-18 |
1993-11-30 |
Patel Ramesh N |
(Exo,exo)-7-oxabicyclo[2.2.1]heptane-2,3-dimethanol; monoacyl ester and diacyl ester
|
US5326898A
(en)
*
|
1992-02-11 |
1994-07-05 |
Allergan, Inc. |
Substituted phenylethenyl compounds having retinoid-like biological activity
|
US6602713B1
(en)
*
|
2001-02-09 |
2003-08-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of protein phosphatase 2 catalytic subunit beta expression
|
US5518993A
(en)
|
1994-08-12 |
1996-05-21 |
Buckman Laboratories International, Inc. |
Pesticidal compositions containing ethoxylated fatty amines for increasing the effectiveness of endothal and salts thereof
|
US5770382A
(en)
*
|
1994-12-30 |
1998-06-23 |
Ligand Pharmaceuticals, Inc. |
Tricyclic retinoids, methods for their production and use
|
US6222055B1
(en)
*
|
1995-07-06 |
2001-04-24 |
Fraunhofer-Gesellschaft Zur Foerderung Der Angwandten Forschung E.V. |
Hydrolyzable and polymerizable and/or polyadditive silanes
|
DE19600707B4
(de)
|
1996-01-11 |
2004-02-19 |
Glüsenkamp, Karl-Heinz, Dr. |
Biyclische Anhydrid-Wirkstoff-Verbindungen, Verfahren zur Herstellung und Verwendung derselben
|
US5968965A
(en)
|
1996-01-30 |
1999-10-19 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6777217B1
(en)
*
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
US5925651A
(en)
|
1996-04-03 |
1999-07-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6387673B1
(en)
*
|
1997-05-01 |
2002-05-14 |
The Salk Institute For Biological Studies |
Compounds useful for the modulation of processes mediated by nuclear hormone receptors, methods for the identification and use of such compounds
|
EP1621077B1
(en)
*
|
1997-10-15 |
2008-09-24 |
Polarx Biopharmaceuticals, Inc. |
Phamaceutical compositions comprising arsenic trioxide for the treatment of a tumor of the central nervous system
|
US6632823B1
(en)
*
|
1997-12-22 |
2003-10-14 |
Merck & Co., Inc. |
Substituted pyridine compounds useful as modulators of acetylcholine receptors
|
WO1999062558A1
(en)
|
1998-06-05 |
1999-12-09 |
Technion Research And Development Foundation Ltd. |
Insulin supplemented infant formula
|
US20040110822A1
(en)
*
|
1998-07-14 |
2004-06-10 |
The University Of Newcastle Research Associates |
Anhydride modified cantharidin analogues useful in the treatment of cancer
|
AUPP466598A0
(en)
|
1998-07-14 |
1998-08-06 |
University Of Newcastle Research Associates Limited, The |
Product and process
|
DE69921147T2
(de)
|
1998-08-07 |
2005-02-24 |
Applied Research Systems Ars Holding N.V. |
Fsh mimetika zur behandlung von infertilität
|
US20020151515A1
(en)
*
|
1999-06-18 |
2002-10-17 |
Roberts Bruce L. |
Preparation and use of superior vaccines
|
US6949624B1
(en)
*
|
1999-08-03 |
2005-09-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cloning of the human nuclear receptor co-repressor gene
|
CN1378450A
(zh)
|
1999-09-08 |
2002-11-06 |
斯隆-凯特林癌症研究院 |
新型细胞分化剂和组蛋白脱乙酰基酶抑制剂及其使用方法
|
US7605185B2
(en)
*
|
1999-11-23 |
2009-10-20 |
Gerhart Graupner |
Treatment of arrhythmia by retinoids affecting signal transduction
|
JP4518627B2
(ja)
|
2000-03-14 |
2010-08-04 |
旭化成イーマテリアルズ株式会社 |
ヒドロキシポリアミド
|
EP1280764B1
(en)
*
|
2000-03-24 |
2010-11-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
PE20020354A1
(es)
*
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
CN1471523A
(zh)
|
2000-09-21 |
2004-01-28 |
ʷ |
咪唑类棉子糖激酶抑制剂
|
US6696483B2
(en)
*
|
2000-10-03 |
2004-02-24 |
Oncopharmaceutical, Inc. |
Inhibitors of angiogenesis and tumor growth for local and systemic administration
|
CN1213050C
(zh)
*
|
2000-11-23 |
2005-08-03 |
拜尔公司 |
氧杂双环[2.2.1]庚烷衍生物,其制备方法和作为农药的用途
|
US20020177692A1
(en)
*
|
2001-04-16 |
2002-11-28 |
Myriad Genetics, Incorporated |
BCL-XL-interacting protein and use thereof
|
AUPR392301A0
(en)
*
|
2001-03-23 |
2001-04-26 |
University Of Newcastle Research Associates Limited, The |
Protein phosphatase inhibitors
|
US20040253637A1
(en)
*
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US6905669B2
(en)
*
|
2001-04-24 |
2005-06-14 |
Supergen, Inc. |
Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
|
US20070015144A9
(en)
*
|
2001-05-25 |
2007-01-18 |
Genset, S.A. |
Human cDNAs and proteins and uses thereof
|
CA2456083C
(en)
|
2001-08-03 |
2012-05-01 |
John K. Inman |
Acylthiols and component thiol compositions as anti-hiv and anti-retroviral agents
|
US20040010045A1
(en)
*
|
2001-09-07 |
2004-01-15 |
Taolin Yi |
Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
|
US7179450B2
(en)
*
|
2001-09-20 |
2007-02-20 |
Medi-Physics, Inc. |
Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe
|
EP2269609A3
(en)
*
|
2001-10-16 |
2012-07-11 |
Sloan-Kettering Institute for Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain with SAHA
|
ATE352319T1
(de)
|
2001-11-06 |
2007-02-15 |
Novartis Pharma Gmbh |
Kombination cyclooxygenase-2 inhibitor/ histone deacetylase inhibitor
|
WO2003070754A1
(fr)
*
|
2002-02-20 |
2003-08-28 |
Minoru Yoshida |
Inhibiteurs d'histone desacetylase et procede de production de ces inhibiteurs
|
US7148257B2
(en)
*
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
US7456219B2
(en)
*
|
2002-03-04 |
2008-11-25 |
Merck Hdac Research, Llc |
Polymorphs of suberoylanilide hydroxamic acid
|
MXPA04007799A
(es)
|
2002-03-08 |
2004-10-15 |
Basf Ag |
Mezclas fungicidas a base de protioconazol con un insecticida.
|
US6809118B2
(en)
*
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
WO2003092616A2
(en)
|
2002-05-01 |
2003-11-13 |
The Cleveland Clinic Foundation |
Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer
|
TW200412967A
(en)
*
|
2002-09-23 |
2004-08-01 |
Schering Corp |
Novel imidazopyrazines as cyclin dependent kinase inhibitors
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
JP2006505793A
(ja)
*
|
2002-11-05 |
2006-02-16 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
膠芽腫の進行に関連する経路を試験するための方法及び材料
|
GB0226855D0
(en)
|
2002-11-18 |
2002-12-24 |
Queen Mary & Westfield College |
Histone deacetylase inhibitors
|
US20040197888A1
(en)
*
|
2002-12-31 |
2004-10-07 |
Armour Christopher D. |
Alternatively spliced isoforms of histone deacetylase 3 (HDAC3)
|
WO2004064727A2
(en)
*
|
2003-01-16 |
2004-08-05 |
Georgetown University |
Method of cancer treatment using hdac inhibitors
|
CA2518407A1
(en)
|
2003-03-12 |
2004-09-23 |
Samaritan Pharmaceuticals, Inc. |
Animal model simulating neurologic disease
|
US7842835B2
(en)
*
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
WO2005025620A2
(en)
*
|
2003-08-13 |
2005-03-24 |
Pharmacia Corporation |
Combination therapy with inhibitors of inducible nitric oxide synthase and alkylating agents
|
WO2005019167A2
(en)
|
2003-08-13 |
2005-03-03 |
Amgen, Inc. |
Melanin concentrating hormone receptor antagonist
|
CA2535585A1
(en)
|
2003-08-21 |
2005-03-03 |
Osaka University |
Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby
|
US7378409B2
(en)
|
2003-08-21 |
2008-05-27 |
Bristol-Myers Squibb Company |
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
|
US7094193B2
(en)
*
|
2003-08-28 |
2006-08-22 |
Philip Morris Usa Inc. |
High speed laser perforation of cigarette tipping paper
|
WO2005034866A2
(en)
|
2003-10-06 |
2005-04-21 |
Glaxo Group Limited |
Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
|
AU2004283313A1
(en)
|
2003-10-24 |
2005-05-06 |
Exelixis, Inc. |
TAO kinase modulators and methods of use
|
AU2004291102A1
(en)
|
2003-11-13 |
2005-06-02 |
Board Of Regents, The University Of Texas System |
Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure
|
GB0328157D0
(en)
|
2003-12-04 |
2004-01-07 |
Imp College Innovations Ltd |
Compounds
|
US20060018970A1
(en)
|
2003-12-12 |
2006-01-26 |
Myogen, Inc. |
Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
|
US8652502B2
(en)
*
|
2003-12-19 |
2014-02-18 |
Cordis Corporation |
Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
|
US20050282893A1
(en)
*
|
2004-01-30 |
2005-12-22 |
Au Jessie L |
Methods and compositions for using suramin, pentosan, polysulfate, telomerase antisense and telomerase inhibitors
|
US20050283841A1
(en)
|
2004-02-02 |
2005-12-22 |
Mckinsey Timothy A |
Inhibition of protein kinase C-related kinase (PRK) as a treatment for cardiac hypertrophy and heart failure
|
US7253204B2
(en)
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
EP1786428B1
(en)
|
2004-08-17 |
2012-05-16 |
The Johns Hopkins University |
Pde5 inhibitor compositions and methods for treating cardiac indications
|
KR100677149B1
(ko)
|
2004-11-12 |
2007-02-02 |
삼성전자주식회사 |
잉크 조성물
|
AU2006228957A1
(en)
|
2005-04-01 |
2006-10-05 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
GB0511266D0
(en)
|
2005-06-02 |
2005-07-13 |
Trust |
Chemical compounds
|
WO2007014033A2
(en)
|
2005-07-22 |
2007-02-01 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure
|
BRPI0614903A2
(pt)
|
2005-08-10 |
2011-04-19 |
Novartis Ag |
método de utilização de iniidores da desacetilase
|
US8759400B2
(en)
|
2005-12-19 |
2014-06-24 |
Methylgene Inc. |
Histone deacetylase inhibitors for enhancing activity of antifungal agents
|
ES2452820T3
(es)
|
2006-04-07 |
2014-04-02 |
Methylgene, Inc. |
Derivados de benzamida como inhibidores de histona desacetilasa
|
US20090018142A9
(en)
*
|
2006-05-02 |
2009-01-15 |
Zhengping Zhuang |
Use of phosphatases to treat tumors overexpressing N-CoR
|
WO2008030617A2
(en)
|
2006-09-07 |
2008-03-13 |
Stemline Therapeutics, Inc. |
Cancer therapy with cantharidin and cantharidin analogs
|
JP2010502681A
(ja)
|
2006-09-08 |
2010-01-28 |
アンスティテュ・グスターブ・ルシ |
プロテインホスファターゼ1、gadd34およびプロテインホスファターゼ1/gadd34複合体の阻害剤、その調製および使用
|
WO2008058342A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Genetic Technologies Limited |
Compounds, compositions and methods for controlling invertebrate pests
|
CA2676422C
(en)
|
2007-02-06 |
2018-10-16 |
Lixte Biotechnology Holdings, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
CA2718472A1
(en)
|
2007-08-03 |
2009-02-12 |
Lixte Biotechnology, Inc. |
Use of phosphatases to treat neuroblastomas and medulloblastomas
|
US8438069B2
(en)
|
2007-08-23 |
2013-05-07 |
Ebay Inc. |
Methods and systems to facilitate a purchase of an item on a network-based marketplace
|
EP2200439B1
(en)
|
2007-10-01 |
2017-03-22 |
Lixte Biotechnology, Inc. |
Hdac inhibitors
|
JP5069091B2
(ja)
|
2007-12-12 |
2012-11-07 |
三菱電機株式会社 |
監視カメラおよび監視カメラシステム
|
WO2010014220A1
(en)
|
2008-08-01 |
2010-02-04 |
Lixte Biotechnology, Inc. |
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
|
EP2309853A4
(en)
|
2008-08-01 |
2012-04-25 |
Lixte Biotechnology Inc |
METHOD FOR CELL MITITULATING BY INHIBITION OF SERIN / THREONINE PHOSPHATASE
|
US8227473B2
(en)
|
2008-08-01 |
2012-07-24 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
WO2010147612A1
(en)
|
2009-06-18 |
2010-12-23 |
Lixte Biotechnology, Inc. |
Methods of modulating cell regulation by inhibiting p53
|
US20120135522A1
(en)
|
2009-06-18 |
2012-05-31 |
Kovach John S |
Methods of modulating cell regulation by inhibiting p53
|